91 Views | 29 Downloads
Ali A. Asadi-Pooya, Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Fax: +98 7136121052.
Ali A. Asadi-Pooya: Honoraria from Cobel Daruo, Tekaje, Sanofi, Actoverco, and RaymandRad; Royalty: Oxford University Press (Book publication); Grant from the National Institute for Medical Research Development. Eugen Trinka has received personal fees from Arvelle/Angelini, Argenix, UCB, Eisai, Bial, Böhringer Ingelheim, Medtronic, Marinus, MedScape, Everpharma, Epilog, GSK, Biogen, Takeda, Liva-Nova, Newbridge, Novartis, Sanofi, Sandoz, Sunovion, GW Pharmaceuticals, Marinus; grants from Austrian Science Fund (FWF), Österreichische Nationalbank, European Union, GSK, Biogen, Eisai, Novartis, Red Bull, Bayer, and UCB; other from Neuroconsult Ges.m.b.H., outside this work. Abdulaziz Ashkanani: Honoraria as a consultant/advisor & speaker for Novartis, Eli Lilly, NewBridge, and Hikma Co. Others: no conflict of interest.
We thank Shiraz University of Medical Sciences.
Ali A. Asadi-Pooya, M.D.: study design, data collection, statistical analyses, and manuscript preparation. Others: data collection and manuscript preparation.
This work was supported by Shiraz University of Medical Sciences. The funding source had no involvement in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.
© 2021 Elsevier Inc. All rights reserved.